Raymond James Financial Inc. purchased a new position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 52,503 shares of the company's stock, valued at approximately $1,103,000. Raymond James Financial Inc. owned approximately 0.13% of Phibro Animal Health at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in PAHC. Thrivent Financial for Lutherans boosted its position in shares of Phibro Animal Health by 23.1% during the 3rd quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company's stock valued at $468,000 after acquiring an additional 3,907 shares during the last quarter. FMR LLC raised its stake in Phibro Animal Health by 22.7% during the third quarter. FMR LLC now owns 39,310 shares of the company's stock valued at $885,000 after purchasing an additional 7,270 shares in the last quarter. Quantbot Technologies LP bought a new position in Phibro Animal Health during the third quarter valued at $70,000. BNP Paribas Financial Markets grew its stake in shares of Phibro Animal Health by 3.1% in the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company's stock worth $548,000 after buying an additional 729 shares in the last quarter. Finally, Jacobs Levy Equity Management Inc. increased its holdings in shares of Phibro Animal Health by 116.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company's stock worth $4,330,000 after buying an additional 103,491 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors.
Phibro Animal Health Trading Down 4.2 %
PAHC stock traded down $0.78 during mid-day trading on Tuesday, reaching $17.88. The company had a trading volume of 197,411 shares, compared to its average volume of 187,547. The firm has a 50 day moving average of $22.48 and a 200 day moving average of $22.56. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a 12 month low of $12.30 and a 12 month high of $26.55. The company has a market capitalization of $724.19 million, a PE ratio of 37.25, a price-to-earnings-growth ratio of 0.45 and a beta of 0.63.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, equities analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current fiscal year.
Phibro Animal Health Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were given a $0.12 dividend. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.68%. Phibro Animal Health's payout ratio is presently 100.00%.
Analyst Ratings Changes
A number of research analysts recently commented on PAHC shares. StockNews.com downgraded shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Barclays upped their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research report on Monday, February 10th. Finally, Morgan Stanley raised their price target on Phibro Animal Health from $20.00 to $25.00 and gave the stock an "equal weight" rating in a research note on Tuesday, December 17th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the stock. Based on data from MarketBeat.com, Phibro Animal Health presently has a consensus rating of "Hold" and a consensus price target of $21.00.
Check Out Our Latest Stock Analysis on Phibro Animal Health
Phibro Animal Health Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Recommended Stories
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
